Horizontal Cells Gene Therapy

Ray Therapeutics

The company develops optogenetic gene therapies to restore vision for patients with blinding retinal diseases.

RhyGaze

This biotechnology company develops optogenetic gene therapies to restore vision for patients with retinal diseases causing blindness.

CIRC Biosciences

This cell therapy company develops chemically induced retinal cells to restore vision for patients with macular degeneration and retinitis pigmentosa.

Vedere

The company develops optogenetics-based gene therapies to restore vision for patients with inherited retinal dystrophies and geographic atrophy.

GenSight Biologics

This company develops gene therapies for patients suffering from neurodegenerative retinal diseases and central nervous system disorders.

Restore Vision

This clinical-stage biotechnology company develops visual restoration gene therapies to treat blindness caused by genetic retinal disorders for patients with retinitis pigmentosa.

InGel Therapeutics

The company develops stem-cell therapies and biodegradable hydrogels for patients suffering from retinal degeneration and blinding diseases like retinitis pigmentosa.

Atsena

This clinical-stage gene therapy company develops genetic medicines to reverse or prevent blindness for patients with inherited retinal diseases.